IGC Pharma, Inc. (IGC)
NYSEAMERICAN: IGC · Real-Time Price · USD
0.2950
-0.0188 (-5.99%)
Apr 25, 2025, 4:00 PM EDT - Market closed
IGC Pharma Employees
IGC Pharma had 67 employees as of March 31, 2024. The number of employees increased by 6 or 9.84% compared to the previous year.
Employees
67
Change (1Y)
6
Growth (1Y)
9.84%
Revenue / Employee
$18,448
Profits / Employee
-$131,478
Market Cap
23.51M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
IGC News
- 1 day ago - IGC Pharma Welcomes Strategic Investment from Advisors - Accesswire
- 4 days ago - IGC Pharma Welcomes Industry Leaders to Advisory Board, Supporting Alzheimer's Innovation and AI-Driven Programs - Accesswire
- 17 days ago - IGC Pharma Expands CALMA Alzheimer's Phase 2 Trial with Prestigious Research Site at Butler Hospital's Memory and Aging Program - Accesswire
- 24 days ago - IGC Pharma Announces CALMA Phase 2 Trial Expansion with the Addition of Miami Jewish Health - Accesswire
- 4 weeks ago - IGC Pharma's Phase 2 Clinical Trial Interim Data Demonstrates Significant Reduction in Sleep Disturbances - Accesswire
- 5 weeks ago - IGC Pharma Announces CALMA Phase 2 Trial Expansion with the Addition of Canadian Hamilton Health Sciences - Accesswire
- 5 weeks ago - IGC Pharma Expands CALMA Trial with Addition of BayCare Health System in Florida - Accesswire
- 6 weeks ago - IGC Pharma Announces Coverage Report by Ascendiant Capital Markets about the "Reports Q3 results. We believe more positive clinical data in 2025 to be strong catalysts for stock. - Accesswire